UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2020-08, Vol.396 (10249), p.479-488

2020

Volltextzugriff (PDF)

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

The Lancet (British edition), 2020-06, Vol.395 (10240), p.1845-1854

2020

Volltextzugriff (PDF)

Rare three-valence-band convergence leading to ultrahigh thermoelectric performance in all-scale hierarchical cubic SnTe

Energy & environmental science, 2024-01, Vol.17 (1), p.158-172

2024

Volltextzugriff (PDF)

Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial

Hepatology international, 2021-12, Vol.15 (6), p.1431-1441

2021

Volltextzugriff (PDF)

Adjuvantation helps to optimise COVID-19 vaccine candidate

The Lancet infectious diseases, 2021-07, Vol.21 (7), p.891-893

2021

Volltextzugriff (PDF)

The S-Trimer (SCB-2019) COVID-19 vaccine and reinfection with SARS-CoV-2

The Lancet infectious diseases, 2022-07, Vol.22 (7), p.916-917

2022

Volltextzugriff (PDF)

Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19

The Lancet (British edition), 2021-12, Vol.398 (10317), p.2134-2135

2021

Volltextzugriff (PDF)

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2015-10, Vol.386 (10002), p.1457-1464

2015

Volltextzugriff (PDF)

Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials

Chinese medical journal, 2021-04, Vol.134 (11), p.1289-1298

2021

Volltextzugriff (PDF)

Novel insight from the first lung transplant of a COVID‐19 patient

European journal of clinical investigation, 2021-01, Vol.51 (1), p.e13443-n/a

2021

Volltextzugriff (PDF)

Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses

PloS one, 2013-05, Vol.8 (5), p.e62924

2013

Volltextzugriff (PDF)

Long-Term Efficacy of a Hepatitis E Vaccine

The New England journal of medicine, 2015-03, Vol.372 (10), p.914-922

2015

Volltextzugriff (PDF)

Machine Learning-Based Prediction of Acute Kidney Injury Following Pediatric Cardiac Surgery: Model Development and Validation Study

Journal of medical Internet research, 2023-01, Vol.25 (1), p.e41142-e41142

2023

Volltextzugriff (PDF)

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2017-02, Vol.389 (10069), p.621-628

2017

Volltextzugriff (PDF)

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

The Lancet (British edition), 2015-06, Vol.385 (9984), p.2272-2279

2015

Volltextzugriff (PDF)

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

The Lancet infectious diseases, 2023-10, Vol.23 (10), p.1143-1152

2023

Volltextzugriff (PDF)

Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial

The Lancet infectious diseases, 2023-09, Vol.23 (9), p.1020-1030

2023

Volltextzugriff (PDF)

A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov

Expert review of vaccines, 2023-12, Vol.22 (1), p.704-713

2023

Volltextzugriff (PDF)

Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants

PloS one, 2012-05, Vol.7 (5), p.e37206

2012

Volltextzugriff (PDF)

Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials

The Journal of infectious diseases, 2023-09, Vol.228 (6), p.715-722

2023

Volltextzugriff (PDF)

Coronavirus disease 2019 vaccines: landscape of global studies and potential risks

Chinese medical journal, 2021-09, Vol.134 (17), p.2037-2044

2021

Volltextzugriff (PDF)

Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial

The Lancet global health, 2017-03, Vol.5 (3), p.e324-e334

2017

Volltextzugriff (PDF)

High precision tracking analysis of cell position and motion fields using 3D U-net network models

Computers in biology and medicine, 2023-03, Vol.154, p.106577-106577, Article 106577

2023

Volltextzugriff (PDF)

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

The Lancet (British edition), 2013-03, Vol.381 (9871), p.1037-1045

2013

Volltextzugriff (PDF)

Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials

Vaccine, 2022-05, Vol.40 (23), p.3216-3227

2022

Volltextzugriff (PDF)

1 – 25 von 25.850

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21.374)
Mit Volltextzugriff
(22.313)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(16.649)
Life Sciences & Biomedicine
(10.524)
Humans
(5.616)
Physical Sciences
(4.254)
Technology
(3.655)
Male
(3.250)
Female
(3.065)
Animals
(2.858)
Chemistry
(2.735)
Middle Aged
(1.809)
Materials Science
(1.798)
Engineering
(1.711)
Adult
(1.641)
Materials Science, Multidisciplinary
(1.432)
Science & Technology - Other Topics
(1.413)
Oncology
(1.369)
Mice
(1.353)
Aged
(1.325)
Physics
(1.282)
Pharmacology & Pharmacy
(1.244)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(10.911)
Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(10.898)
MEDLINE
(8.260)
IngentaConnect Journals
(4.771)
Access via ScienceDirect (Elsevier)
(4.630)
Journals@Ovid Ovid Full Text
(3.891)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.987)
SpringerNature Journals
(2.674)
Access via Wiley Online Library
(2.522)
Wiley Online Library Full Collection 2018
(1.553)
Single Journals
(1.381)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.319)
Nature Journals Online
(883)
IEEE Electronic Library (IEL)
(666)
Taylor & Francis Journals Auto-Holdings Collection
(587)
Nexis Uni
(509)
Taylor & Francis:Master (3349 titles)
(491)
Taylor & Francis Current Content Access
(473)
Oxford Journals Current Collection
(320)
Ebook Central Perpetual and DDA
(236)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(305)
中华医学杂志
(297)
Chinese Medical Journal
(204)
Scientific Reports
(204)
Applied Mechanics And Materials
(198)
Ssrn Electronic Journal
(183)
Nature Communications
(148)
Wuli Xuebao
(139)
Advanced Materials Research
(133)
Chinese Medical Journal/chinese Medical Journal
(126)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Rare three-valence-band convergence leading to ultrahigh thermoelectric performance in all-scale hierarchical cubic SnTe

Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial

Adjuvantation helps to optimise COVID-19 vaccine candidate

The S-Trimer (SCB-2019) COVID-19 vaccine and reinfection with SARS-CoV-2

Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial

Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials

Novel insight from the first lung transplant of a COVID‐19 patient

Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses

Long-Term Efficacy of a Hepatitis E Vaccine

Machine Learning-Based Prediction of Acute Kidney Injury Following Pediatric Cardiac Surgery: Model Development and Validation Study

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial

A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov

Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants

Environmental Impact Assessment for the Use of an Orally Aerosolized Adenovirus Type-5 Vector-Based COVID-19 Vaccine in Randomized Clinical Trials

Coronavirus disease 2019 vaccines: landscape of global studies and potential risks

Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial

High precision tracking analysis of cell position and motion fields using 3D U-net network models

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials

Suchergebnisse filtern